"While the drugs may ultimately prove to be truly transformative for health, they are currently a net cost to the system. For a patient's care to 'break even,' the price of the drug would need to drop by 40% to 80%, or the patient would need to remain healthy and off the drug (without regaining weight) for many years, a scenario that current data on 'rebound weight gain' suggests is incredibly difficult to achieve."  MORE >>